Collagen Structure, Folding and Function

Osteogenesis Imperfecta: A Translational Approach to Brittle Bone Disease

Volumn , Issue , 2013, Pages 71-84

  Makareeva, Elena ^a   Leikin, Sergey ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Collagen; ER stress; Osteogenesis imperfecta; Protein folding; Triple helix

Indexed keywords

EID: 84902432078     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-397165-4.00007-1     Document Type: Chapter

References (171)

1. Forlino A, Cabral WA, Barnes AM, Marini JC New perspectives on osteogenesis imperfecta. Nat Rev Endocrinol 2011, 7(9):540-557.
2. Morello R, Bertin TK, Chen Y, Hicks J, Tonachini L, Monticone M, et al. CRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 2006, 127(2):291-304.
3. Barnes AM, Cliang W, Morello R, Cabral WA, Weis M, Eyre DR, et al. Brief report: deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta. N Engl J Med 2006, 355(26):2757-2764.
4. Cabral WA, Chang W, Barnes AM, Weis M, Scott MA, Leikin S, et al. Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta. Nat Genet 2007, 39(3):359-365.
5. Choi JW, Sutor SL, Lindquist L, Evans GL, Madden BJ, Bergen HR, et al. Severe osteogenesis imperfecta in cyclophilin B-deficient mice. PLoS Genet 2009, 5(12):e1000750.
6. van Dijk FS, Nesbitt IM, Zwikstra EH, Nikkels PG, Piersma SR, Fratantoni SA, et al. PPIB mutations cause severe osteogenesis imperfecta. Am J Hum Genet 2009, 85(4):521-527.
7. Barnes AM, Carter EM, Cabral WA, Weis M, Chang W, Makareeva E, et al. Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding. N Engl J Med 2010, 362(6):521-528.
8. Alanay Y, Avaygan H, Camacho N, Utine GE, Boduroglu K, Aktas D, et al. Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta. Am J Hum Genet 2010, 86(4):551-559.
9. Droegemueller C, Becker D, Brunner A, Haase B, Kircher P, Seeliger F, et al. A missense mutation in the SERPINH1 gene in dachshunds with osteogenesis imperfecta. PloS Genet 2009, 5:7.
10. Christiansen HE, Schwarze U, Pyott SM, AlSwaid A, Al Balwi M, Alrasheed S, et al. Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta. Am J Hum Genet 2010, 86(3):389-398.
11. Shaheen R, Al-Owain M, Sakati N, Alzayed ZS, Alkuraya FS FKBP10 and Bruck syndrome: phenotypic heterogeneity or call for reclassification?. Am J Hum Genet 2010, 87(2):306-307. Erratum 571.
12. Kelley BP, Malfait F, Bonafe L, Baldridge D, Homan E, Symoens S, et al. Mutations in FKBP10 cause recessive osteogenesis imperfecta and type 1 Bruck syndrome. J Bone Miner Res 2011, 26(3):666-672. doi:10.1002/jbmr.250.
13. Ha-Vinh R, Alanay Y, Bank RA, Campos-Xavier AB, Zankl A, Superti-Furga A, et al. Phenotypic and molecular characterization of Bruck syndrome (osteogenesis imperfecta with contractures of the large joints) caused by a recessive mutation in PLOD2. Am J Med Genet A 2004, 131(2):115-120.
14. Puig-Hervas MT, Temtamy S, Aglan M, Valencia M, Martinez-Glez V, Ballesta-Martinez MJ, et al. Mutations in PLOD2 cause autosomal recessive connective tissue disorders within the Bruck syndrome-osteogenesis imperfecta phenotypic spectrum. Hum Mutat 2012, 33(10):1444-1449. doi:10.1002/humu.22133.
15. Martinez-Glez V, Valencia M, Caparros-Martin JA, Aglan M, Temtamy S, Tenorio J, et al. Identification of a mutation causing deficient BMP1/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta. Hum Mutat 2012, 33(2):343-350.
16. Becker J, Semler O, Gilissen C, Li Y, Bolz HJ, Giunta C, et al. Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta. Am J Hum Genet 2011, 88(3):362-371.
17. Homan EP, Rauch F, Grafe I, Lietman C, Doll JA, Dawson B, et al. Mutations in SERPINF1 cause osteogenesis imperfecta type VI. J Bone Miner Res 2011, 26(12):2798-2803.
18. Lapunzina P, Aglan M, Temtamy S, Caparros-Martin JA, Valencia M, Leton R, et al. Identification of a frameshift mutation in Osterix in a patient with recessive osteogenesis imperfecta. Am J Hum Genet 2010, 87(1):110-114.
19. Jimenez SA, Bashey RI, Benditt M, Yankowski R Identification of collagen alpha1(I) trimer in embryonic chick tendons and calvaria. Biochem Biophys Res Commun 1977, 78(4):1354-1361.
20. Moro L, Smith BD Identification of collagen alpha1(I) trimer and normal type I collagen in a polyoma virus-induced mouse tumor. Arch Biochem Biophys 1977, 182(1):33-41.
21. Shapiro FD, Eyre DR Collagen polymorphism in extracellular matrix of human osteosarcoma. J Natl Cancer Inst 1982, 69(5):1009-1016.
22. Yamagata S, Yamagata T FBJ virus-induced osteosarcoma contains type I, type I trimer, type III as well as type V collagens. J Biochem 1984, 96(1):17-26.
23. Pucci Minafra I, Luparello C, Sciarrino S, Tomasino RM, Minafra S Quantitative determination of collagen types present in the ductal infiltrating carcinoma of human mammary gland. Cell Biol Int Rep 1985, 9(3):291-296.
24. Asokan R, Puvanakrishnan R, Ravichandran LV, Kokila V, Reddy GK, Dhar SC Purification and characterization of collagens from rat fibrosarcoma induced by 3-methylcholanthrene. Mol Cell Biochem 1993, 121(2):99-107.
25. Makareeva E, Han S, Vera JC, Sackett DL, Holmbeck K, Phillips CL, et al. Carcinomas contain a matrix metalloproteinase-resistant isoform of type I collagen exerting selective support to invasion. Cancer Res 2010, 70(11):4366-4374.
26. Rojkind M, Giambrone MA, Biempica L Collagen types in normal and cirrhotic liver. Gastroenterology 1979, 76(4):710-719.
27. Narayanan AS, Page RC, Meyers DF Characterization of collagens of diseased human gingiva. Biochemistry 1980, 19(22):5037-5043.
28. Ehrlich HP, Brown H, White BS Evidence for type V and I trimer collagens in Dupuytren's Contracture palmar fascia. Biochem Med 1982, 28(3):273-284.
29. Han S, Makareeva E, Kuznetsova NV, DeRidder AM, Sutter MB, Losert W, et al. Molecular mechanism of type I collagen homotrimer resistance to mammalian collagenases. J Biol Chem 2010, 285(29):22276-22281.
30. Chipman SD, Sweet HO, McBride DJ, Davisson MT, Marks SC, Shuldiner AR, et al. Defective pro-alpha-2(I) collagen-synthesis in a recessive mutation in mice - a model of human osteogenesis imperfecta. Proc Natl Acad Sci USA 1993, 90(5):1701-1705.
31. Schwarze U, Hata RI, McKusick VA, Shinkai H, Hoyme HE, Pyeritz RE, et al. Rare autosomal recessive cardiac valvular form of Ehlers-Danlos syndrome results from mutations in the COL1A2 gene that activate the nonsense-mediated RNA decay pathway. Am J Hum Genet 2004, 74(5):917-930.
32. Malfait F, Symoens S, Coucke P, Nunes L, De Almeida S, De Paepe A Total absence of the alpha 2(I) chain of collagen type I causes a rare form of Ehlers-Danlos syndrome with hypermobility and propensity to cardiac valvular problems. J Med Genet 2006, 43:7.
33. Birk DE, Bruckner P Collagen suprastructures. Top Curr Chem 2005, 247:185-205.
34. Canty EG, Kadler KE Procollagen trafficking, processing and fibrillogenesis. J Cell Sci 2005, 118(7):1341-1353.
35. Myllyharju J, Kivirikko KI Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends Genet 2004, 20(1):33-43.
36. Engel J, Bachinger HP Structure, stability and folding of the collagen triple helix. Top Curr Chem 2005, 247:7-33.
37. Engel J, Prockop DJ The zipper-like folding of collagen triple helices and the effects of mutations that disrupt the zipper. Annu Rev Biophys Biophys Chem 1991, 20:137-152.
38. Brodsky B, Thiagarajan G, Madhan B, Kar K Triple-helical peptides: an approach to collagen conformation, stability, and self-association. Biopolymers 2008, 89(5):345-353.
39. Shoulders MD, Raines RT Collagen structure and stability. Annu Rev Biochem 2009, 78:929-958.
40. Gorres KL, Raines RT Prolyl 4-hydroxylase. Crit Rev Biochem Mol Biol 2010, 45(2):106-124.
41. Myllyharju J Prolyl 4-hydroxylases, key enzymes in the synthesis of collagens and regulation of the response to hypoxia, and their roles as treatment targets. Ann Med 2008, 40(6):402-417.
42. Persikov AV, Ramshaw JA, Brodsky B Prediction of collagen stability from amino acid sequence. J Biol Chem 2005, 280(19):19343-19349.
43. Kuznetsova NV, McBride DJ, Leikin S Changes in thermal stability and microunfolding pattern of collagen helix resulting from the loss of alpha 2(I) chain in osteogenesis imperfecta murine. J Mol Biol 2003, 331(1):191-200.
44. Ryhanen L, Zaragoza EJ, Uitto J Conformational stability of type I collagen triple helix: evidence for temporary and local relaxation of the protein conformation using a proteolytic probe. Arch Biochem Biophys 1983, 223(2):562-571.
45. Hofmann H, Voss T, Kuhn K, Engel J Localization of flexible sites in thread-like molecules from electron micrographs. Comparison of interstitial, basement membrane and intima collagens. J Mol Biol 1984, 172(3):325-343.
46. Kadler KE, Hojima Y, Prockop DJ Assembly of type I collagen fibrils de novo. Between 37 and 41 degrees C the process is limited by micro-unfolding of monomers. J Biol Chem 1988, 263(21):10517-10523.
47. Privalov PL Stability of proteins. Proteins which do not present a single cooperative system. Adv Protein Chem 1982, 35:1-104.
48. Spotila LD, Colige A, Sereda L, Constantinoudeltas CD, Whyte MP, Riggs BL, et al. Mutation analysis of coding sequences for type-I procollagen in individuals with low bone-density. J Bone Miner Res 1994, 9(6):923-932.
49. Reis FC, Alexandrino F, Steiner CE, Norato DY, Cavalcanti DP, Sartorato EL Molecular findings in Brazilian patients with osteogenesis imperfecta. J Appl Genet 2005, 46(1):105-108.
50. Pollitt R, McMahon R, Nunn J, Bamford R, Afifi A, Bishop N, et al. Mutation analysis of COL1A1 and COL1A2 in patients diagnosed with osteogenesis imperfecta type I-IV. Hum Mutat 2006, 27(7):716.
51. Cabral WA, Makareeva E, Letocha AD, Scribanu N, Fertala A, Steplewski A, et al. Y-position cysteine substitution in type I collagen (alpha 1(I) R888C/p.R1066C) is associated with osteogenesis imperfecta/Ehlers-Danlos syndrome phenotype. Hum Mutat 2007, 28(4):396-405.
52. Malfait F, Symoens S, De Backer J, Hermanns-Le T, Sakalihasan N, Lapiere CM, et al. Three arginine to cysteine substitutions 4 in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood. Hum Mutat 2007, 28(4):387-395.
53. Lund AM, Joensen F, Christensen E, Duno M, Skovby F, Schwartz M A novel arginine-to-cysteine substitution in the triple helical region of the alpha 1(I) collagen chain in a family with an osteogenesis imperfecta/Ehlers-Danlos phenotype. Clin Genet 2008, 73(1):97-101.
54. Dalgleish R, Osteogenesis imperfecta & Ehlers-Danlos syndrome variant databases. Available from:<>. http://www.le.ac.uk/ge/collagen/.
55. Nuytinck L, Freund M, Lagae L, Pierard GE, Hermanns-Le T, De Paepe A Classical Ehlers-Danlos syndrome caused by a mutation in type I collagen. Am J Hum Genet 2000, 66(4):1398-1402.
56. Gensure RC, Makitie O, Barclay C, Chan C, DePalma SR, Bastepe M, et al. A novel COL1A1 mutation in infantile cortical hyperostosis (Caffey disease) expands the spectrum of collagen-related disorders. J Clin Invest 2005, 115(5):1250-1257.
57. Cho TJ, Moon HJ, Cho DY, Park MS, Lee DY, Yoo WJ, et al. The c.3040C>T mutation in COL1A1 is recurrent in Korean patients with infantile cortical hyperostosis (Caffey disease). J Hum Genet 2008, 53(10):947-949.
58. Miles CA, Bailey AJ Thermally labile domains in the collagen molecule. Micron 2001, 32(3):325-332.
59. Bachinger HP, Davis JM Sequence specific thermal stability of the collagen triple helix. Int J Biol Macromol 1991, 13(3):152-156.
60. Makareeva E, Mertz EL, Kuznetsova NV, Sutter MB, DeRidder AM, Cabral WA, et al. Structural heterogeneity of type I collagen triple helix and its role in osteogenesis imperfecta. J Biol Chem 2008, 283(8):4787-4798.
61. Koide T, Nishikawa Y, Asada S, Yamazaki CM, Takahara Y, Homma DL, et al. Specific recognition of the collagen triple helix by chaperone HSP47. II. The HSP47-binding structural motif in collagens and related proteins. J Biol Chem 2006, 281(16):11177-11185.
62. Marini JC, Forlino A, Cabral WA, Barnes AM, San Antonio JD, Milgrom S, et al. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat 2007, 28(3):209-221.
63. Leikina E, Mertts MV, Kuznetsova N, Leikin S Type I collagen is thermally unstable at body temperature. Proc Natl Acad Sci USA 2002, 99(3):1314-1318.
64. Makareeva E, Leikin S Procollagen triple helix assembly: an unconventional chaperone-assisted folding paradigm. PLoS One 2007, 2:10.
65. Miles CA, Burjanadze TV, Bailey AJ The kinetics of the thermal denaturation of collagen in unrestrained rat tail tendon determined by differential scanning calorimetry. J Mol Biol 1995, 245(4):437-446.
66. Persikov AV, Xu Y, Brodsky B Equilibrium thermal transitions of collagen model peptides. Protein Sci 2004, 13(4):893-902.
67. Xu Y Thermal stability of collagen triple helix. Methods Enzymol 2009, 466:211-232.
68. Burjanadze TV New analysis of the phylogenetic change of collagen thermostability. Biopolymers 2000, 53(6):523-528.
69. Miles CA, Ghelashvili M Polymer-in-a-box mechanism for the thermal stabilization of collagen molecules in fibers. Biophys J 1999, 76(6):3243-3252.
70. Koide T, Nagata K Collagen biosynthesis. Top Curr Chem 2005, 247:85-114.
71. Lamande SR, Bateman JF Procollagen folding and assembly: the role of endoplasmic reticulum enzymes and molecular chaperones. Semin Cell Dev Biol 1999, 10(5):455-464.
72. Anfinsen CB Principles that govern the folding of protein chains. Science 1973, 181(96):223-230.
73. Dill KA, Ozkan SB, Shell MS, Weikl TR The protein folding problem. Annu Rev Biophys 2008, 37:289-316.
74. Englander SW, Mayne L, Krishna MM Protein folding and misfolding: mechanism and principles. Q Rev Biophys 2007, 40(4):287-326.
75. Cali T, Vanoni O, Molinari M The endoplasmic reticulum: crossroads for newly synthesized polypeptide chains. Prog Mol Biol Transl Sci 2008, 83:135-179.
76. Clark PL Protein folding in the cell: reshaping the folding funnel. Trends Biochem Sci 2004, 29(10):527-534.
77. Hartl FU, Hayer-Hartl M Converging concepts of protein folding in vitro and in vivo. Nat Struct Mol Biol 2009, 16(6):574-581.
78. Malhotra JD, Kaufman RJ The endoplasmic reticulum and the unfolded protein response. Semin Cell Dev Biol 2007, 18(6):716-731.
79. Yoshida H ER stress and diseases. FEBS J 2007, 274(3):630-658.
80. Makareeva E, Aviles NA, Leikin S Chaperoning osteogenesis: new protein-folding disease paradigms. Trends Cell Biol 2011, 21(3):168-176.
81. Ishida Y, Nagata K Hsp47 as a collagen-specific molecular chaperone. Methods Enzymol 2011, 499:167-182.
82. Koide T, Asada S, Takahara Y, Nishikawa Y, Nagata K, Kitagawa K Specific recognition of the collagen triple helix by chaperone HSP47: minimal structural requirement and spatial molecular orientation. J Biol Chem 2006, 281(6):3432-3438.
83. Ishikawa Y, Vranka J, Wirz J, Nagata K, Baechinger HP The rough endoplasmic reticulum-resident FK506-binding protein FKBP65 is a molecular chaperone that interacts with collagens. J Biol Chem 2008, 283(46):31584-31590.
84. Ishikawa Y, Wirz J, Vranka JA, Nagata K, Baechinger HP Biochemical characterization of the prolyl 3-hydroxylase 1*cartilage-associated protein*cyclophilin B complex. J Biol Chem 2009, 284(26):17641-17647.
85. Barnes AM, Cabral WA, Weis M, Makareeva E, Mertz EL, Leikin S, et al. Absence of FKBP10 in recessive type XI OI leads to diminished collagen cross-linking and reduced collagen deposition in extracellular matrix. Hum Mutat 2012, 33(11):1589-1598. doi:10.1002/humu.22139.
86. Chessler SD, Byers PH BiP binds type I procollagen pro alpha chains with mutations in the carboxyl-terminal propeptide synthesized by cells from patients with osteogenesis imperfecta. J Biol Chem 1993, 268(24):18226-18233.
87. Lamande SR, Chessler SD, Golub SB, Byers PH, Chan D, Cole WG, et al. Endoplasmic reticulum-mediated quality control of type I collagen production by cells from osteogenesis imperfecta patients with mutations in the pro alpha 1 (I) chain carboxyl-terminal propeptide which impair subunit assembly. J Biol Chem 1995, 270(15):8642-8649.
88. Fitzgerald J, Lamande SR, Bateman JF Proteasomal degradation of unassembled mutant type I collagen pro-alpha1(I) chains. J Biol Chem 1999, 274(39):27392-27398.
89. Forlino A, Kuznetsova NV, Marini JC, Leikin S Selective retention and degradation of molecules with a single mutant alpha1(I) chain in the Brtl IV mouse model of OI. Matrix Biol 2007, 26(8):604-614.
90. Forlino A, Tani C, Rossi A, Lupi A, Campari E, Gualeni B, et al. Differential expression of both extracellular and intracellular proteins is involved in the lethal or nonlethal phenotypic variation of BrtlIV, a murine model for osteogenesis imperfecta. Proteomics 2007, 7(11):1877-1891.
91. Ishida Y, Yamamoto A, Kitamura A, Lamande SR, Yoshimori T, Bateman JF, et al. Autophagic elimination of misfolded procollagen aggregates in the endoplasmic reticulum as a means of cell protection. Mol Biol Cell 2009, 20(11):2744-2754.
92. Ekeowa UI, Gooptu B, Belorgey D, Hagglof P, Karlsson-Li S, Miranda E, et al. alpha1-Antitrypsin deficiency, chronic obstructive pulmonary disease and the serpinopathies. Clin Sci (Lond) 2009, 116(12):837-850.
93. Ishida Y, Nagata K Autophagy eliminates a specific species of misfolded procollagen and plays a protective role in cell survival against ER stress. Autophagy 2009, 5(8):1217-1219.
94. Kojima T, Miyaishi O, Saga S, Ishiguro N, Tsutsui Y, Iwata H The retention of abnormal type I procollagen and correlated expression of HSP 47 in fibroblasts from a patient with lethal osteogenesis imperfecta. J Pathol 1998, 184(2):212-218.
95. Lisse TS, Thiele F, Fuchs H, Hans W, Przemeck GK, Abe K, et al. ER stress-mediated apoptosis in a new mouse model of osteogenesis imperfecta. PLoS Genet 2008, 4(2):e7.
96. Bateman JF, Boot-Handford RP, Lamande SR Genetic diseases of connective tissues: cellular and extracellular effects of ECM mutations. Nat Rev Genet 2009, 10(3):173-183.
97. Beck K, Chan VC, Shenoy N, Kirkpatrick A, Ramshaw JA, Brodsky B Destabilization of osteogenesis imperfecta collagen-like model peptides correlates with the identity of the residue replacing glycine. Proc Natl Acad Sci USA 2000, 97(8):4273-4278.
98. Xiao J, Madhan B, Li Y, Brodsky B, Baum J Osteogenesis imperfecta model peptides: incorporation of residues replacing Gly within a triple helix achieved by renucleation and local flexibility. Biophys J 2011, 101(2):449-458.
99. Cheng H, Rashid S, Yu Z, Yoshizumi A, Hwang E, Brodsky B Location of glycine mutations within a bacterial collagen protein affects degree of disruption of triple-helix folding and conformation. J Biol Chem 2011, 286(3):2041-2046.
100. Hyde TJ, Bryan MA, Brodsky B, Baum J Sequence dependence of renucleation after a Gly mutation in model collagen peptides. J Biol Chem 2006, 281(48):36937-36943.
101. Raghunath M, Bruckner P, Steinmann B Delayed triple helix formation of mutant collagen from patients with osteogenesis imperfecta. J Mol Biol 1994, 236(3):940-949.
102. Persikov AV, Pillitteri RJ, Amin P, Schwarze U, Byers PH, Brodsky B Stability related bias in residues replacing glycines within the collagen triple helix (Gly-Xaa-Yaa) in inherited connective tissue disorders. Hum Mutat 2004, 24(4):330-337.
103. Makareeva E, Cabral WA, Marini JC, Leikin S Molecular mechanism of alpha 1(I)-osteogenesis imperfecta/Ehlers-Danlos syndrome - unfolding of an N-anchor domain at the N-terminal end of the type I collagen triple helix. J Biol Chem 2006, 281(10):6463-6470.
104. Nagai N, Hosokawa M, Itohara S, Adachi E, Matsushita T, Hosokawa N, et al. Embryonic lethality of molecular chaperone Hsp47 knockout mice is associated with defects in collagen biosynthesis. J Cell Biol 2000, 150(6):1499-1506.
105. Ono T, Miyazaki T, Ishida Y, Uehata M, Nagata K Direct in vitro and in vivo evidence for interaction between Hsp47 protein and collagen triple helix. J Biol Chem 2012, 287(9):6810-6818.
106. Gotkin MG, Ripley CR, Lamande SR, Bateman JF, Bienkowski RS Intracellular trafficking and degradation of unassociated proalpha2 chains of collagen type I. Exp Cell Res 2004, 296(2):307-316.
107. Stefanovic B, Brenner DA 5' stem-loop of collagen alpha 1(I) mRNA inhibits translation in vitro but is required for triple helical collagen synthesis in vivo. J Biol Chem 2003, 278(2):927-933.
108. Patterson GH, Hirschberg K, Polishchuk RS, Gerlich D, Phair RD, Lippincott-Schwartz J Transport through the Golgi apparatus by rapid partitioning within a two-phase membrane system. Cell 2008, 133(6):1055-1067.
109. Chessler SD, Byers PH Defective folding and stable association with protein disulfide isomerase/prolyl hydroxylase of type I procollagen with a deletion in the pro alpha 2(I) chain that preserves the Gly-X-Y repeat pattern. J Biol Chem 1992, 267(11):7751-7757.
110. Fromme JC, Schekman R COPII-coated vesicles: flexible enough for large cargo?. Curr Opin Cell Biol 2005, 17(4):345-352.
111. Wilson DG, Phamluong K, Li L, Sun M, Cao TC, Liu PS, et al. Global defects in collagen secretion in a Mia3/TANGO1 knockout mouse. J Cell Biol 2011, 193(5):935-951.
112. Saito K, Chen M, Bard F, Chen S, Zhou H, Woodley D, et al. TANGO1 facilitates cargo loading at endoplasmic reticulum exit sites. Cell 2009, 136(5):891-902.
113. Saito K, Yamashiro K, Ichikawa Y, Erlmann P, Kontani K, Malhotra V, et al. cTAGE5 mediates collagen secretion through interaction with TANGO1 at endoplasmic reticulum exit sites. Mol Biol Cell 2011, 22(13):2301-2308.
114. Jin L, Pahuja KB, Wickliffe KE, Gorur A, Baumgartel C, Schekman R, et al. Ubiquitin-dependent regulation of COPII coat size and function. Nature 2012, 482(7386):495-500.
115. Canty EG, Lu Y, Meadows RS, Shaw MK, Holmes DF, Kadler KE Coalignment of plasma membrane channels and protrusions (fibripositors) specifies the parallelism of tendon. J Cell Biol 2004, 165(4):553-563.
116. Canty-Laird EG, Lu Y, Kadler KE Stepwise proteolytic activation of type I procollagen to collagen within the secretory pathway of tendon fibroblasts in situ. Biochem J 2012, 441(2):707-717.
117. Bateman JF, Golub SB Assessment of procollagen processing defects by fibroblasts cultured in the presence of dextran sulphate. Biochem J 1990, 267(3):573-577.
118. Wallis GA, Starman BJ, Schwartz MF, Byers PH Substitution of arginine for glycine at position 847 in the triple-helical domain of the alpha 1 (I) chain of type I collagen produces lethal osteogenesis imperfecta. Molecules that contain one or two abnormal chains differ in stability and secretion. J Biol Chem 1990, 265(30):18628-18633.
119. Bateman JF, Mascara T, Chan D, Cole WG Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfecta. Biochem J 1984, 217(1):103-115.
120. Kadler KE, Hojima Y, Prockop DJ Assembly of collagen fibrils de novo by cleavage of the type I pC-collagen with procollagen C-proteinase. Assay of critical concentration demonstrates that collagen self-assembly is a classical example of an entropy-driven process. J Biol Chem 1987, 262(32):15696-15701.
121. Kadler KE, Hill A, Canty-Laird EG Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleators. Curr Opin Cell Biol 2008, 20(5):495-501.
122. Gioia R, Panaroni C, Besio R, Palladini G, Merlini G, Giansanti V, et al. Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy. Stem Cells 2012, 30(7):1465-1476.
123. Uveges TE, Collin-Osdoby P, Cabral WA, Ledgard F, Goldberg L, Bergwitz C, et al. Cellular mechanism of decreased bone in Brtl mouse model of OI: imbalance of decreased osteoblast function and increased osteoclasts and their precursors. J Bone Miner Res 2008, 23(12):1983-1994.
124. Kuznetsova NV, Forlino A, Cabral WA, Marini JC, Leikin S Structure, stability and interactions of type I collagen with GLY349-CYS substitution in alpha 1(I) chain in a murine Osteogenesis Imperfecta model. Matrix Biol 2004, 23(2):101-112.
125. Panaroni C, Gioia R, Lupi A, Besio R, Goldstein SA, Kreider J, et al. In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knockin murine model for classical, dominant osteogenesis imperfecta. Blood 2009, 114(2):459-468.
126. Fleischmajer R, Olsen BR, Timpl R, Perlish JS, Lovelace O Collagen fibril formation during embryogenesis. Proc Natl Acad Sci USA 1983, 80(11):3354-3358.
127. Eyre DR, Shapiro FD, Aldridge JF A heterozygous collagen defect in a variant of the Ehlers-Danlos syndrome type VII. Evidence for a deleted amino-telopeptide domain in the pro-alpha 2(I) chain. J Biol Chem 1985, 260(20):11322-11329.
128. Romanic AM, Adachi E, Hojima Y, Engel J, Prockop DJ Polymerization of pNcollagen I and copolymerization of pNcollagen I with collagen I. A kinetic, thermodynamic, and morphologic study. J Biol Chem 1992, 267(31):22265-22271.
129. Hulmes DJ, Kadler KE, Mould AP, Hojima Y, Holmes DF, Cummings C, et al. Pleomorphism in type I collagen fibrils produced by persistence of the procollagen N-propeptide. J Mol Biol 1989, 210(2):337-345.
130. Cole WG, Chan D, Chambers GW, Walker ID, Bateman JF Deletion of 24 amino acids from the pro-alpha 1(I) chain of type I procollagen in a patient with the Ehlers-Danlos syndrome type VII. J Biol Chem 1986, 261(12):5496-5503.
131. Nusgens BV, Verellendumoulin C, Hermannsle T, Depaepe A, Nuytinck L, Pierard GE, et al. Evidence for a relationship between Ehlers-Danlos type-VII-C in humans and bovine dermatosporaxis. Nat Genet 1992, 1(3):214-217.
132. Steinmann B, Tuderman L, Peltonen L, Martin GR, McKusick VA, Prockop DJ Evidence for a structural mutation of procollagen type I in a patient with the Ehlers-Danlos syndrome type VII. J Biol Chem 1980, 255(18):8887-8893.
133. Cabral WA, Makareeva E, Colige A, Letocha AD, Ty JM, Yeowell HN, et al. Mutations near amino end of alpha 1(I) collagen cause combined osteogenesis imperfecta/Ehlers-Danlos syndrome by interference with N-propeptide processing. J Biol Chem 2005, 280(19):19259-19269.
134. Asharani PV, Keupp K, Semler O, Wang WS, Li Y, Thiele H, et al. Attenuated BMP1 function compromises osteogenesis, leading to bone fragility in humans and zebrafish. Am J Hum Genet 2012, 90(4):661-674.
135. Lindahl K, Barnes AM, Fratzl-Zelman N, Whyte MP, Hefferan TE, Makareeva E, et al. COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta. Hum Mutat 2011, 32(6):598-609.
136. van der Slot AJ, Zuurmond AM, Bardoel AF, Wijmenga C, Pruijs HE, Sillence DO, et al. Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis. J Biol Chem 2003, 278(42):40967-40972.
137. Shaheen R, Al-Owain M, Faqeih E, Al-Hashmi N, Awaji A, Al-Zayed Z, et al. Mutations in FKBP10 cause both Bruck syndrome and isolated osteogenesis imperfecta in humans. Am J Med Genet A 2011, 155A(6):1448-1452.
138. Hyry M, Lantto J, Myllyharju J Missense mutations that cause Bruck syndrome affect enzymatic activity, folding, and oligomerization of lysyl hydroxylase 2. J Biol Chem 2009, 284(45):30917-30924.
139. Meiri D, Tazat K, Cohen-Peer R, Farchi-Pisanty O, Aviezer-Hagai K, Avni A, et al. Involvement of Arabidopsis ROF2 (FKBP65) in thermotolerance. Plant Mol Biol 2010, 72(1-2):191-203.
140. Murphy LA, Ramirez EA, Trinh VT, Herman AM, Anderson VC, Brewster JL Endoplasmic reticulum stress or mutation of an EF-hand Ca(2+)-binding domain directs the FKBP65 rotamase to an ERAD-based proteolysis. Cell Stress Chaperones 2011, 16(6):607-619.
141. Broadhead ML, Becerra SP, Choong PF, Dass CR The applied biochemistry of PEDF and implications for tissue homeostasis. Growth Factors 2010, 28(4):280-285.
142. Sekiya A, Okano-Kosugi H, Yamazaki CM, Koide T Pigment epithelium-derived factor (PEDF) shares binding sites in collagen with heparin/heparan sulfate proteoglycans. J Biol Chem 2011, 286(30):26364-26374.
143. Venturi G, Gandini A, Monti E, Dalle Carbonare L, Corradi M, Vincenzi M, et al. Lack of expression of SERPINF1, the gene coding for pigment epithelium-derived factor, causes progressively deforming osteogenesis imperfecta with normal type I collagen. J Bone Miner Res 2012, 27(3):723-728.
144. Doll JA, Stellmach VM, Bouck NP, Bergh ARJ, Lee C, Abramson LP, et al. Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas. Nat Med 2003, 9(6):774-780.
145. Huang Q, Wang SJ, Sorenson CM, Sheibani N PEDF-deficient mice exhibit an enhanced rate of retinal vascular expansion and are more sensitive to hyperoxia-mediated vessel obliteration. Exp Eye Res 2008, 87(3):226-241.
146. Glorieux FH, Ward LM, Rauch F, Lalic L, Roughley PJ, Travers R Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. J Bone Miner Res 2002, 17(1):30-38.
147. Park K, Lee K, Zhang B, Zhou T, He X, Gao GQ, et al. Identification of a novel inhibitor of the canonical Wnt pathway. Mol Cell Biol 2011, 31(14):3038-3051.
148. Akiyama T, Dass CR, Shinoda Y, Kawano H, Tanaka S Choong PFM. PEDF regulates osteoclasts via osteoprotegerin and RANKL. Biochem Biophys Res Commun 2010, 391(1):789-794.
149. Vranka JA, Sakai LY, Bachinger HP Prolyl 3-hydroxylase 1, enzyme characterization and identification of a novel family of enzymes. J Biol Chem 2004, 279(22):23615-23621.
150. Vranka JA, Pokidysheva E, Hayashi L, Zientek K, Mizuno K, Ishikawa Y, et al. Prolyl 3-hydroxylase 1 null mice display abnormalities in fibrillar collagen-rich tissues such as tendons, skin, and bones. J Biol Chem 2010, 285(22):17253-17262.
151. Chang W, Barnes AM, Cabral WA, Bodurtha JN, Marini JC Prolyl 3-hydroxylase 1 and CRTAP are mutually stabilizing in the endoplasmic reticulum collagen prolyl 3-hydroxylation complex. Hum Mol Genet 2010, 19(2):223-234.
152. Bachinger HP, Bruckner P, Timpl R, Prockop DJ, Engel J Folding mechanism of the triple helix in type-III collagen and type-III pN-collagen. Role of disulfide bridges and peptide bond isomerization. Eur J Biochem 1980, 106(2):619-632.
153. Steinmann B, Bruckner P, Superti-Furga A Cyclosporin A slows collagen triple-helix formation in vivo: indirect evidence for a physiologic role of peptidyl-prolyl cis-trans-isomerase. J Biol Chem 1991, 266(2):1299-1303.
154. Smith T, Ferreira LR, Hebert C, Norris K, Sauk JJ Hsp47 and cyclophilin B traverse the endoplasmic reticulum with procollagen into pre-Golgi intermediate vesicles. A role for Hsp47 and cyclophilin B in the export of procollagen from the endoplasmic reticulum. J Biol Chem 1995, 270(31):18323-18328.
155. Horibe T, Yosho C, Okada S, Tsukamoto M, Nagai H, Hagiwara Y, et al. The chaperone activity of protein disulfide isomerase is affected by cyclophilin B and cyclosporin A in vitro. J Biochem 2002, 132(3):401-407.
156. Meunier L, Usherwood YK, Chung KT, Hendershot LM A subset of chaperones and folding enzymes form multiprotein complexes in endoplasmic reticulum to bind nascent proteins. Mol Biol Cell 2002, 13(12):4456-4469.
157. Kozlov G, Bastos-Aristizabal S, Maattanen P, Rosenauer A, Zheng F, Killikelly A, et al. Structural basis of cyclophilin B binding by the calnexin/calreticulin P-domain. J Biol Chem 2010, 285(46):35551-35557.
158. Ishikawa Y, Vranka JA, Boudko SP, Pokidysheva E, Mizuno K, Zientek K, et al. The mutation in cyclophilin B that causes hyperelastosis cutis in the American Quarter Horse does not affect peptidyl-prolyl cis-trans isomerase activity, but shows altered cyclophilin B-protein interactions and affects collagen folding. J Biol Chem 2012, 287(26):22253-22265.
159. Marini JC, Cabral WA, Barnes AM Null mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfecta. Cell Tissue Res 2010, 339(1):59-70.
160. Baldridge D, Lennington J, Weis M, Homan EP, Jiang MM, Munivez E, et al. Generalized connective tissue disease in Crtap-/-mouse. PLoS One 2010, 5(5):e10560.
161. Valli M, Barnes A, Gallanti A, Cabral W, Viglio S, Weis M, et al. Deficiency of CRTAP in non-lethal recessive osteogenesis imperfecta reduces collagen deposition into matrix. Clin Genet 2012, 82(5):453-459. doi:10.1111/j.399-0004.2011.01794.x.
162. Weis MA, Hudson DM, Kim L, Scott M, Wu JJ, Eyre DR Location of 3-hydroxyproline residues in collagen types I, II, III, and V/XI implies a role in fibril supramolecular assembly. J Biol Chem 2010, 285(4):2580-2590.
163. Byers PH, Wallis GA, Willing MC Osteogenesis imperfecta: translation of mutation to phenotype. J Med Genet 1991, 28(7):433-442.
164. Bateman JF, Moeller I, Hannagan M, Chan D, Cole WG Characterization of three osteogenesis imperfecta collagen alpha 1(I) glycine to serine mutations demonstrating a position-dependent gradient of phenotypic severity. Biochem J 1992, 288(Pt 1):131-135.
165. Kuivaniemi H, Tromp G, Prockop DJ Mutations in collagen genes: causes of rare and some common diseases in humans. Faseb J 1991, 5(7):2052-2060.
166. Cabral WA, Milgrom S, Letocha AD, Moriarty E, Marini JC Biochemical screening of type I collagen in osteogenesis imperfecta: detection of glycine substitutions in the amino end of the alpha chains requires supplementation by molecular analysis. J Med Genet 2006, 43(8):685-690.
167. Bachinger HP, Morris NP, Davis JM Thermal stability and folding of the collagen triple helix and the effects of mutations in osteogenesis imperfecta on the triple helix of type I collagen. Am J Med Genet 1993, 45(2):152-162.
168. Di Lullo GA, Sweeney SM, Korkko J, Ala-Kokko L, San Antonio JD Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen. J Biol Chem 2002, 277(6):4223-4231.
169. Sweeney SM, Orgel JP, Fertala A, McAuliffe JD, Turner KR, Di Lullo GA, et al. Candidate cell and matrix interaction domains on the collagen fibril, the predominant protein of vertebrates. J Biol Chem 2008, 283(30):21187-21197.
170. Marini JC, Lewis MB, Wang Q, Chen KJ, Orrison BM Serine for glycine substitutions in type-I collagen in 2 cases of type-IV osteogenesis imperfecta (OI) - additional evidence for a regional model of OI pathophysiology. J Biol Chem 1993, 268(4):2667-2673.
171. Hidvegi T, Mirnics K, Hale P, Ewing M, Beckett C, Perlmutter DH Regulator of G signaling 16 is a marker for the distinct encloplasmic reticulum stress state associated with aggregated mutant alpha(1)-antitrypsin Z in the classical form of alpha(1)-antitrypsin deficiency. J Biol Chem 2007, 282(38):27769-27780.